Philip Jonsson

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir, Ryma Benayed, Ronak Shah et al. · Nature Medicine · 2017 · 3.5K citations

Medicine, Genetics, Oncology +16

Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

Hira Rizvi, Francisco Sánchez-Vega, Konnor La et al. · Journal of Clinical Oncology · 2018 · 1.4K citations · Full text

Medicine, Immunology, Oncology +17

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Pedram Razavi, Matthew T. Chang, Guotai Xu et al. · Cancer Cell · 2018 · 1K citations · Full text

Medicine, Genetics, Oncology +14

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

Catherine C. Coombs, Ahmet Zehir, Sean M. Devlin et al. · Cell stem cell · 2017 · 855 citations · Full text

Medicine, Hematology, Oncology +11

Genome doubling shapes the evolution and prognosis of advanced cancers

Craig M. Bielski, Ahmet Zehir, Alexander Penson et al. · Nature Genetics · 2018 · 692 citations

Life Sciences, Genetics, Oncology +12